3.93
0.61 (18.37%)
| Penutupan Terdahulu | 3.32 |
| Buka | 3.61 |
| Jumlah Dagangan | 463,627 |
| Purata Dagangan (3B) | 93,686 |
| Modal Pasaran | 763,821,888 |
| Harga / Jualan (P/S) | 23.36 |
| Harga / Buku (P/B) | 26.16 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 13 Feb 2026 |
| Margin Keuntungan | -67.73% |
| Margin Operasi (TTM) | -115.65% |
| EPS Cair (TTM) | -0.080 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 40.80% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 25.78% |
| Nisbah Semasa (MRQ) | 3.17 |
| Aliran Tunai Operasi (OCF TTM) | -12.93 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -14.06 M |
| Pulangan Atas Aset (ROA TTM) | -19.93% |
| Pulangan Atas Ekuiti (ROE TTM) | -55.43% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Menurun |
| Medical Devices (Global) | Bercampur | Menurun | |
| Stok | SS Innovations International In | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 1.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 2.0 |
| Purata | 0.88 |
|
SS Innovations International Inc is a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. The company designs, manufactures, and markets an advanced, next-generation, and affordable surgical robotic system called the SSi Mantra, and the instruments and accessories used with SSi Mantra to perform a wide range of soft-tissue, robotically assisted surgeries. The company earns the majority of its revenue from India. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Mid Growth |
| % Dimiliki oleh Orang Dalam | 83.38% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 13 Jan 2026 | Pengumuman | SS Innovations Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2025 |
| 08 Jan 2026 | Pengumuman | SS Innovations Appoints Milan Rao as Global Chief Operating Officer and Chief Financial Officer |
| 06 Jan 2026 | Pengumuman | SS Innovations Develops New Instruments to Advance Robotic Surgery in Large, Underserved Patient Segments, including Pediatric and Cardiac Markets |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |